Delcath Systems, Inc. (DCTH) vs NeuroPace, Inc. (NPCE)
- Delcath Systems, Inc. DCTH 14.08 −4.93%
- NeuroPace, Inc. NPCE 12.24 −4.23%
Delcath Systems, Inc. and NeuroPace, Inc. are both Medical Devices companies. Delcath Systems, Inc. is the larger, with a market value of $513.9M against $438.7M — 1.2× the size. NeuroPace, Inc. has negative trailing earnings, so its P/E is not meaningful; Delcath Systems, Inc. trades at 1,408×. Delcath Systems, Inc. grew revenue faster over the last twelve months: 35.9% against 21.7%. Delcath Systems, Inc. has the higher net margin (0.56% vs −18.6%) and the higher return on invested capital (−4.49% vs −44.6%). Across the 18 metrics below, Delcath Systems, Inc. leads on 15 and NeuroPace, Inc. on 3.
Valuation
Profitability
| Metric | DCTH | NPCE | Medical Devices median |
|---|---|---|---|
| Gross margin | 87.05% | 78.38% | 56.01% |
| Operating margin | (1.90%) | (13.33%) | (15.03%) |
| Net margin | 0.56% | (18.58%) | (20.40%) |
| Free cash flow margin | 18.35% | (11.29%) | (7.24%) |
| Return on equity | 0.47% | (122.05%) | (15.32%) |
| Return on assets | 0.42% | (18.82%) | (19.72%) |
| Return on invested capital | (4.49%) | (44.64%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack